5-ethyl-2,3-dihydro-1,2-oxazol-3-one, 97%, 250mg

Ethyl 4-hydroxyquinoline-3-carboxylate, 95.0%, 25g

Methyl 2H,3H,4H-pyrano[2,3-c]pyridine-6-carboxylate, 97%, 100mg

5-Bromo-N1-isopropylbenzene-1,2-diamine, 95+%, 100mg

1-Bromo-2-methyl-3,4-dinitrobenzene, 95.0%, 100mg

(4-Ethoxycarbonimidoyl-phenyl)-acetic acid ethyl ester; hydrochloride, 95.0%, 1g

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-O-methyl-L-tyrosine>98.0%(HPLC)(T)1g

(R)-N-Boc-3-Fluorophenylalanine, 95.0%, 10g

1-Nitro-2-(trifluoromethoxy)benzene, 95.0%, 5g

GC capillary column ROTI®Cap-1701 MS, 30 m, 0.32 mm, 0.25 µm, 1 Piece(s)

6-FLUORO-3-METHYL-1H-PYRAZOLO[3,4-B]PYRIDINE, 95%, 500mg

Dimethyl 1,4-cyclohexanedicarboxylate, 95.0%, 100g

Methyl 3-amino-5-fluoro-benzo[b]thiophene-2-carboxylate, 95.0%, 5g